Vicor Technologies names vice-president and accounting officer
This article was originally published in Clinica
Thomas Bohannon is named vice-president and chief accounting officer for Vicor Technologies (Boca Raton, Florida), an early-stage biotechnology company that develops software for diagnostic purposes. The appointment has been made in anticipation of the commercialisation of the firm’s PD2i software, which "evaluates electrophysiological potentials to predict future pathological events". Mr Bohannon has been an accountant and financial officer for more than 40 years. Beginning his career at Ernst & Young as a senior manager, he most recently headed up his own business offering financial advice for management companies.
You may also be interested in...
Three upcoming medical device regulations were discussed at BSI’s Hong Kong Forum in April that will be important to the success of Hong Kong’s voluntary regulatory system, the Medical Device Administrative Control System.
Saudi Arabia has adopted an interim marketing authorisation regulation under which, possibly as early as 2010, only medical devices that have been approved by the Saudi Arabia Food and Drug Administration will be allowed on the market1. Additionally, only medical devices that comply with the regulations in force in the European Union, the US, Canada, Japan or Australia – ie in the jurisdiction of a Global Harmonization Task Force founding member - will be eligible for marketing in the country2,3.
The government of Canada has launched a marketing campaign to encourage consumers and healthcare professionals to use the country’s MedEffect initiative for reporting suspected adverse events related to healthcare products1.